XVIVO PERFUSION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 373 SEK | +4.63% |
|
+17.85% | +13.20% |
| Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
| Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Evolution of the average Target Price on Xvivo Perfusion AB
Price target over the last 5 years
History of analyst recommendation changes
8fe3c657fc61ff6e3.UKUzBxDEOcrKKzrgwMwBNLInc6yuqyu-Gp-MCPAhEFA.Nd8DNkmLXZyzb32smOFzB9lGQuTa41_3edP5P6lqYyJj0mpXJYFBhb5cfw~b45493ae0832556f6140a093bbc4b541
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
373
SEK
Average target price
408
SEK
Spread / Average Target
+9.38%
High Price Target
468
SEK
Spread / Highest target
+25.47%
Low Price Target
340
SEK
Spread / Lowest Target
-8.85%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- XVIVO Stock
- Consensus Xvivo Perfusion AB
